Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.42 |
| ▸ | RXRB | P28702 | 2/20 | 0.42 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20796148 | 0.90 | RXRA (0.50) | RXRARXRBRAPGEF4CNR2PTGS2 | |
| SCHEMBL23625589 | 0.90 | ABL1 (0.39) | RXRARXRBRAPGEF4 | |
| SCHEMBL23072542 | 0.87 | TTR (0.36) | RXRARXRBRAPGEF4CNR2 | |
| SCHEMBL25813276 | 0.85 | AHR (0.45) | RXRARXRBCNR2PTGS2 | |
| SCHEMBL13782228 | 0.84 | ALDH1A1 (0.41) | RXRARXRB | |
| SCHEMBL19781968 | 0.80 | MAPT (0.46) | RXRARXRB | |
| SCHEMBL10068159 | 0.80 | ACHE (0.42) | RXRARXRBRAPGEF4PTGS2 | |
| SCHEMBL25944996 | 0.80 | KIF11 (0.45) | CNR2 | |
| SCHEMBL19004134 | 0.76 | ACHE (0.50) | RAPGEF4PTGS2 | |
| SCHEMBL4392845 | 0.76 | ACHE (0.50) | RAPGEF4PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | RXRA 348/4885RXRB 675/4885RAPGEF4 3829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.